GSK Revenue Growth (YoY) Analysis
Updated 830h ago·SEC filings & market data
Key Takeaway
Revenue growth of 5.3% measures how much GSK's sales increased compared to the same period one year earlier, indicating moderate top-line expansion for a business of its size.
Sector Performance
32th percentileGSK
5.3%
Sector Median
9.1%
Sector Avg
14.8%
Prior Period
1.5%(Jun 2026)
Deep Analysis
Revenue growth of 5.3% measures how much GSK's sales increased compared to the same period one year earlier, indicating moderate top-line expansion for a business of its size.
That level trails the sector median of 9.2%, placing GSK at the 33rd percentile among sector peers, meaning roughly two-thirds of comparable companies grew faster. Trend data is absent: no year-over-year change,
Frequently Asked Questions
What does the Revenue Growth (YoY) tell investors about GSK?
Year-over-year revenue acceleration is one of the strongest signals of business momentum. Sustained >15% growth is rare and typically re-rated by the market.
How is the Revenue Growth (YoY) calculated?
Revenue Growth (YoY) is calculated as: (Revenue_t - Revenue_t-4) / Revenue_t-4.
Learn More About Revenue Growth (YoY)
The Formula
(Revenue_t - Revenue_t-4) / Revenue_t-4
Why It Matters
Year-over-year revenue acceleration is one of the strongest signals of business momentum. Sustained >15% growth is rare and typically re-rated by the market.
Master GSK's Valuation
Get the complete institutional research report covering all fundamental and technical metrics.
View full GSK research report →GSK
5.3%
Sector Median
9.1%
Sector Avg
14.8%
How GSK's Revenue Growth (YoY) compares to sector peers.
Also Analyze
Not financial advice. Research tool only. Data may be delayed.